JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
$0.00
Substrate for ErbB-2/HER-2 receptor tyrosine kinase with N- terminal biotin
See full description
Muniyan et al (2015) ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells. Cell Signal, 27(11) 2261 PMID: 26257301
Qiu et al (2008) Mechanism of Activation and Inhibition of the HER4/ErbB4 Kinase. Structure, 16(3) 460 PMID: 18334220
Collier et al (2013) Carboxyl Group Footprinting Mass Spectrometry and Molecular Dynamics Identify Key Interactions in the HER2-HER3 Receptor Tyrosine Kinase Interface. J. Biol. Chem. 288(35) 25254. PMID: 23843458
Human epidermal growth factor receptor 2 (HER-2)/epidermal growth factor receptor-2 (ErbB-2), is a key receptor linked to metastasis in tumours. The oncogenic ErbB-2 receptor has intrinsic receptor tyrosine kinase (RTK) activity, the receptor is activated by ligand binding which induces receptor dimerization. These RTK complexes can activate mitogen-activated protein kinase (MAPK) and phosphoinositol 3′-kinase (PI3K)/Akt pathways. This peptide has been identified as a substrate for HER-2/ErbB-2 as it is phosphorylated upon receptor activation and therefore acts as a marker for receptor activation in kinases assays. Contains a covalently attached N-terminal biotin tag for convenient detection and purification.
crb1000260h
0.5mg
crb1000260j
1mg
